Methods |
For characteristics see Foster 2015a2
|
Participants |
|
Interventions |
|
Outcomes |
|
Notes |
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Not described |
Allocation concealment (selection bias) |
Low risk |
An Interactive Web Response System was used |
Blinding of participants and personnel (performance bias) All outcomes |
High risk |
Described as open‐label |
Blinding of outcome assessment (detection bias) All outcomes |
High risk |
Described as open‐label |
Incomplete outcome data (attrition bias) All outcomes |
Low risk |
Only 5 participants dropped out |
Selective reporting (reporting bias) |
High risk |
SVR 24 was not reported as described in the prepublished protocol (NCT02220998 and supplementary material at NEJM.org) |
Vested‐interest bias |
High risk |
The trial was funded by a company that might have an interest in a given result (Gilead Sciences) |
Other bias |
Low risk |
The trial appeared to be free of other components that could put it at risk of bias |